BioWorld - Monday, January 12, 2026

BioWorld Science

Aug. 6, 2012

View Archived Issues

Roche reflects on accomplishments of second quarter 2012

Read More

Sirolimus reduces skin cancer occurrence in renal transplant recipients

Read More

Pol I inhibitor shows anticancer potency in vitro and in vivo

Read More

MEK inhibitor improves survival in METRIC trial

Read More

Kyowa Hakko Kirin presents overview of first half 2012

Read More

Researchers at Novartis disclose novel beta-secretase inhibitors

Read More

Sanofi updates R&D progress of second quarter 2012

Read More

New sodium channel blockers designed by Pfizer

Read More

Korean group prepares new GPR119 receptor ligands

Read More

Bionor Pharma presents new candidate vaccines

Read More

Belgian scientists divulge novel antiviral alphabodies

Read More

Beta Pharma patents novel protein kinase inhibitors

Read More

GSK confirms submissions for dabrafenib and trametinib

Read More

New technique offers alternative to gene therapy

Read More

Zaltrap approved in U.S. for cancer indication

Read More

ACT advances stem cell trial for dry AMD

Read More

FDA assigns PDUFA action date for enzalutamide NDA

Read More

Ono kicks off first-in-human study of peptide-cocktail vaccine

Read More

Pluristem reports second successful compassionate use of PLX cells

Read More

Daiichi Sankyo presents overview of first quarter fiscal 2012

Read More

UCB reviews events of first half 2012

Read More

U.S. university and Novartis form global alliance for anticancer T-cell immunotherapies

Read More

NIH awards grant to support study of Immuron candidate drug for steatohepatitis

Read More

Marina Biotech grants Novartis license for CRN technology

Read More